Sangamo Therapeutics

-$0.01 (-0.09%) As of 1:06 PM UTC pre-market

Why Robinhood?

You can buy or sell SGMO and other stocks, options, and ETFs commission-free!

About SGMO

Sangamo Therapeutics, Inc. Common Stock, also called Sangamo Therapeutics, is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins.

CEO
Alexander D. Macrae
Employees
413
Headquarters
Brisbane, California
Founded
1995

SGMO Key Statistics

Market Cap
1.69B
Price-Earnings Ratio
Dividend Yield
Average Volume
872.50K
High Today
$11.90
Low Today
$11.62
Open Price
$11.78
Volume
564.22K
52 Week High
$19.43
52 Week Low
$8.51

SGMO Earnings

-$0.37
-$0.23
-$0.10
$0.04
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Actual
Expected Aug 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure